Answers are grounded in this paper and cite their sources.
This perspective examines drug pricing and transparency in healthcare, suggesting implications for policy change.
This Perspective examines various aspects of the Great Healthcare Plan related to drug pricing, including over-the-counter expansion; subsidies, rebates, and cost sharing; and price transparency.
No takes yet. Share an insight, caveat, or question.
Robertson et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: